Evidence map›Paper›PMID 35301726›Full record

Trial reportClinical cardiology2022

Cavotricuspid isthmus ablation guided by force-time integral - A randomized study.

Dimitrios Asvestas, Vasileios Sousonis, George Kotsovolis, Stavros Karanikas, Anastasia Xintarakou, Eleftherios Sakadakis, Angelos G Rigopoulos, Andreas S Kalogeropoulos, Panos Vardas, Stylianos Tzeis

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Clinical cardiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Lattice-tip vs. standard irrigated focal-tip catheter for radiofrequency ablation of the cavotricuspid isthmus - the LINEAR randomized trial.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Trial
  2. Trial
  3. Feasibility and acute outcomes of cavotricuspid isthmus ablation using the circular-array pulsed field system.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Article
  4. Article
  5. Article
  6. 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Dimitrios AsvestasDepartment of Cardiology, Mitera Hospital, Hygeia Group, Athens, Greece.
Vasileios SousonisDepartment of Cardiology, Mitera Hospital, Hygeia Group, Athens, Greece.ORCID https://orcid.org/0000-0002-8041-4574
George KotsovolisDepartment of Cardiology, Mitera Hospital, Hygeia Group, Athens, Greece.
Stavros KaranikasDepartment of Cardiology, Mitera Hospital, Hygeia Group, Athens, Greece.
Anastasia XintarakouDepartment of Cardiology, Mitera Hospital, Hygeia Group, Athens, Greece.ORCID http://orcid.org/0000-0003-0135-8023
Eleftherios SakadakisDepartment of Cardiology, Mitera Hospital, Hygeia Group, Athens, Greece.
Angelos G RigopoulosDepartment of Cardiology, Mitera Hospital, Hygeia Group, Athens, Greece.
Andreas S KalogeropoulosDepartment of Cardiology, Mitera Hospital, Hygeia Group, Athens, Greece.
Panos VardasDepartment of Cardiology, Mitera Hospital, Hygeia Group, Athens, Greece.
Stylianos TzeisDepartment of Cardiology, Mitera Hospital, Hygeia Group, Athens, Greece.
Mitera Hospital · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundForce-time integral (FTI) is an ablation marker of lesion quality and transmurality. A target FTI of 400 gram-seconds (gs) has been shown to improve durability of pulmonary vein isolation, following atrial fibrillation ablation. However, relevant targets for cavotricuspid isthmus (CTI) ablation are lacking. HYPOTHESIS: We sought to investigate whether CTI ablation with 600 gs FTI lesions is associated with reduced rate of transisthmus conduction recovery compared to 400 gs lesions.

methodsFifty patients with CTI-dependent flutter were randomized to ablation using 400 gs (FTI400 group, n = 26) or 600 gs FTI lesions (FTI600 group, n = 24). The study endpoint was spontaneous or adenosine-mediated recovery of transisthmus conduction, after a 20-min waiting period.

resultsThe study endpoint occurred in five patients (19.2%) in group FTI400 and in four patients (16.7%) in group FTI600, p = .81. First-pass CTI block was similar in both groups (50% in FTI400 vs. 54.2% in FTI600, p = .77). There were no differences in the total number of lesions, total ablation time, procedure time and fluoroscopy duration between the two groups. There were no major complications in any group. In the total population, patients not achieving first-pass CTI block had significantly higher rate of acute CTI conduction recovery, compared to those with first-pass block (29.2% vs. 7.7% respectively, p = .048).

conclusionsCTI ablation using 600 gs FTI lesions is not associated with reduced spontaneous or adenosine-mediated recurrence of transisthmus conduction, compared to 400 gs lesions.

Indexed as

Atrial FlutterCatheter AblationPulmonary VeinsAdenosineHumansTreatment OutcomeTricuspid ValveAdenosineablationatrial fluttercavotricuspid isthmusforce-time integral

Identifiers

PMID35301726
PMCPMC9045076
OpenAlexW4221108980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.